News and Media Coverage

Kerala-based life sciences company PNB Vesper announced that it has successfully completed the COVID-19 Phase 2 Clinical Trials and submitted the final report of its proprietary drug PNB-001 (GPP-Baladol) to the Drug Controller General of India (DCGI). GPP-Baladol is a … Continued

Kochi-based PNB Vesper Life Sciences NSE 1.17 % has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency … Continued

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use. The … Continued

PNB Vesper, a leading Kerala based life sciences company, has announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General … Continued

PNB Vesper, a leading Kerala based Life Sciences Company, today announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. PNB Vesper, a Kerala based Life Science Company has successfully … Continued

PNB Vesper, a Kerala-based life sciences company, announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General of India (DCGI) … Continued

India-based life sciences company PNB Vesper has reportedly completed the Phase II clinical trials of its proprietary drug, PNB-001 (GPP-Baladol), on Covid-19 patients. In all the initial preclinical studies, the drug has demonstrated positive results, IANS reported. In addition, it … Continued

PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients. The company had received approval from the Drug Controller General … Continued

PNB Vesper life science Pvt Ltd, is a leading Indian Pharma Research company with a vision to “work towards a healthier World by developing novel, safe, and affordable medicines to prevent and treat unmet medical needs”. PNB Vesper has today … Continued